创伤性与非创伤性急性脑损伤的脑脊液蛋白质组学反应:一项前瞻性研究
这项前瞻性蛋白质组学研究纳入50例需脑室置管监测ICP至少5天的严重急性脑损伤患者和12例无急性脑损伤的择期未破裂动脉瘤夹闭患者,在损伤后24小时内及之后每24小时收集脑室脑脊液共5天,用数据非依赖采集和SWATH质谱比较蛋白表达。结果发现急性脑损伤患者与无急性脑损伤者之间有255种蛋白表达显著差异(p<0.01),创伤性与非创伤性急性脑损伤之间有96种蛋白差异(p<0.05),39种蛋白与创伤性急性脑损伤患者严重颅内高压风险增加相关(p<0.05)。胶质纤维酸性蛋白在ICP≥30 mm Hg或死亡患者中表达更高(log2倍数变化+2.4;p<0.001)。作者结论认为脑室脑脊液蛋白表达失调可能与严重颅内高压和死亡风险增加相关。
要点
- 严重急性脑损伤患者脑室脑脊液中胶质纤维酸性蛋白表达在ICP≥30 mm Hg或死亡者中更高(log2倍数变化+2.4;p<0.001)。
- 急性脑损伤患者与无急性脑损伤者之间有255种脑室脑脊液蛋白表达显著差异(p<0.01)。
- 创伤性与非创伤性急性脑损伤之间有96种脑室脑脊液蛋白表达差异(p<0.05)。
- 39种脑室脑脊液蛋白与创伤性(对比非创伤性)急性脑损伤患者严重颅内高压(ICP≥30 mm Hg)风险增加相关(p<0.05)。
- 蛛网膜下腔出血与创伤性脑损伤之间、3个月格拉斯哥结局评分良好与不良之间,蛋白表达无显著差异。
适用人群与场景
- 连续纳入的严重急性脑损伤、预期需脑室置管监测颅内压至少5天的患者。
- 因择期未破裂脑动脉瘤夹闭入院的无急性脑损伤患者。
诊断标准与关键阈值
- 严重颅内高压定义为颅内压≥30 mm Hg。
- 3个月功能状态用格拉斯哥结局量表评估,分为良好与不良。
红旗征与不能漏的情况
- 颅内压≥30 mm Hg的严重颅内高压。
- 死亡。
研究设计与关键结果
- 前瞻性蛋白质组学研究,纳入50例急性脑损伤患者(蛛网膜下腔出血23例、创伤性脑损伤15例、颅内出血6例、缺血性卒中3例、其他3例)和12例无急性脑损伤患者。
- 急性脑损伤患者与无急性脑损伤者之间有255种蛋白表达显著差异(p<0.01);7种与炎症增加、凋亡、氧化应激及细胞对缺氧和损伤反应相关的蛋白存在日内和日间表达差异。
- 胶质纤维酸性蛋白在伴有严重颅内高压(ICP≥30 mm Hg)或死亡的急性脑损伤患者中表达高于不伴有者(log2倍数变化+2.4;p<0.001)。
- 创伤性与非创伤性急性脑损伤之间有96种蛋白表达差异(p<0.05);6种与结构损伤、补体激活和胆固醇代谢相关的蛋白存在日内和日间差异。
- 39种脑室脑脊液蛋白与创伤性(对比非创伤性)急性脑损伤患者严重颅内高压(ICP≥30 mm Hg)风险增加相关(p<0.05)。
- 蛛网膜下腔出血与创伤性脑损伤之间、3个月格拉斯哥结局评分良好与不良之间,蛋白表达无显著差异。
证据类型、等级与局限
- 证据类型:前瞻性蛋白质组学分析研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,急性脑损伤后脑室脑脊液蛋白表达失调可能与严重颅内高压和死亡风险增加相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Quantitative analysis of ventricular cerebrospinal fluid (vCSF) proteins following acute brain injury (ABI) may help identify pathophysiological pathways and potential biomarkers that can predict unfavorable outcome.
METHODS: In this prospective proteomic analysis study, consecutive patients with severe ABI expected to require intraventricular catheterization for intracranial pressure (ICP) monitoring for at least 5 days and patients without ABI admitted for elective clipping of an unruptured cerebral aneurysm were included. vCSF samples were collected within the first 24 h after ABI and ventriculostomy insertion and then every 24 h for 5 days. In patients without ABI, a single vCSF sample was collected at the time of elective clipping. Data-independent acquisition and sequential window acquisition of all theoretical spectra (SWATH) mass spectrometry were used to compare differences in protein expression in patients with ABI and patients without ABI and in patients with traumatic and nontraumatic ABI. Differences in protein expression according to different ICP values, intensive care unit outcome, subarachnoid hemorrhage (SAH) versus traumatic brain injury (TBI), and good versus poor 3-month functional status (assessed by using the Glasgow Outcome Scale) were also evaluated. vCSF proteins with significant differences between groups were compared by using linear models and selected for gene ontology analysis using R Language and the Panther database.
RESULTS: We included 50 patients with ABI (SAH n = 23, TBI n = 15, intracranial hemorrhage n = 6, ischemic stroke n = 3, others n = 3) and 12 patients without ABI. There were significant differences in the expression of 255 proteins between patients with and without ABI (p < 0.01). There were intraday and interday differences in expression of seven proteins related to increased inflammation, apoptosis, oxidative stress, and cellular response to hypoxia and injury. Among these, glial fibrillary acidic protein expression was higher in patients with ABI with severe intracranial hypertension (ICH) (ICP ≥ 30 mm Hg) or death compared to those without (log 2 fold change: + 2.4; p < 0.001), suggesting extensive primary astroglial injury or death. There were differences in the expression of 96 proteins between patients with traumatic and nontraumatic ABI (p < 0.05); intraday and interday differences were observed for six proteins related to structural damage, complement activation, and cholesterol metabolism. Thirty-nine vCSF proteins were associated with an increased risk of severe ICH (ICP ≥ 30 mm Hg) in patients with traumatic compared with nontraumatic ABI (p < 0.05). No significant differences were found in protein expression between patients with SAH versus TBI or between those with good versus poor 3-month Glasgow Outcome Scale score.
CONCLUSIONS: Dysregulated vCSF protein expression after ABI may be associated with an increased risk of severe ICH and death.
参考来源
- Santacruz CA, Vincent JL, Duitama J, et al. The Cerebrospinal Fluid Proteomic Response to Traumatic and Nontraumatic Acute Brain Injury: A Prospective Study. Neurocrit Care. 2022. PMID: 35523916. doi:10.1007/s12028-022-01507-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。